The goal of this prospective cohort device study is to assess clinical usage and impact, diagnostic performance, and prognostic performance of the Sepsis ImmunoScore.
Who can participate
Inclusion Criteria:
* Adult (age 18 years or older) patients presenting to hospitals and emergency departments of medical institutions across the United States.
* Adult (age 18 years or older) patients suspected of sepsis.
Exclusion Criteria:
* none